Resources & Evidence Contact us

146 Results:

Sort By:

Late-onset sepsis reduced in premature infants fed Prolacta’s 100% human milk-based fortifiers as part of an exclusive human milk diet

Type: Press Releases

Topic(s): Clinical Studies Clinical Studies on Prolact/Humavant CR Late-Onset Sepsis

Prolacta Bioscience fortifiers reduce risk of serious lung disease and hospital costs among premature infants, compared to cow milk-based fortifiers

Type: Press Releases

Topic(s): Bronchopulmonary Dysplasia (BPD)

NICU parents help other new parents through difficult times

Type: Parent Stories Press Releases

Topic(s): Parents

Research suggests some premature infants may go home from the NICU Up to 3 weeks earlier when fed Prolacta’s 100% human milk-based nutritional products; those with bronchopulmonary dysplasia may benefit the most

Type: Press Releases

Topic(s): Bronchopulmonary Dysplasia (BPD) Length of hospital stay

Multiple NICUs showed improved growth & lung health in premature infants by fortifying feeds safely in the first days of life with Prolacta’s 100% human milk-based fortifiers

Type: Press Releases

Topic(s): Bronchopulmonary Dysplasia (BPD) Early Fortification Feeding Protocols Growth Necrotizing Entercolitis (NEC) Product

The preemie parent’s survival guide to the NICU now reflects the latest clinical advancements to better support parents worldwide

Type: Press Releases

Topic(s): Company Growth Parents

Preterm infants fed Prolacta’s 100% human milk-based fortifiers achieved catch-up growth by age 2 with appropriate neurodevelopmental outcomes, study says

Type: Press Releases

Topic(s): Growth Long-Term outcomes

Head-to-head subgroup analysis of human milk–based fortifiers finds significant improvements in health and brain growth measure for preemies fed mother’s milk plus Prolacta’s fortifiers

Type: Press Releases

Topic(s): Growth Neurodevelopmental Outcomes Total Parenteral Nutrition (TPN) Use

Prolacta Bioscience reassures hospitals of the safety of its human milk-based nutritional products during the coronavirus pandemic

Type: Press Releases

Topic(s): Clinical Studies Clinical Studies on Prolact/Humavant CR Pasteurization Quality & Safety

Not finding the reference you’re looking for?

Use our main search field or email us at info@prolacta.com